Case series of protective ventilation for ARDS using partial extracorporeal CO2 removal

Rauch S.1, Roth H.2, Deininger T.2, Kuhwald A.2, Lund L.3, Fischer M.1 1ALB FILS KLINIKEN, Anesthesiology, Göppingen, Germany, 2ALB FILS KLINIKEN, Internal Medicine, Göppingen, Germany, 3ALung Technologies Inc., Pittsburgh, United States Poster presentation from the EuroELSO 2015 4th International Congress Objectives In the ARDS Network trial of low tidal volume ventilation, hypercapnia and respiratory acidosis (read more)

A retrospective observational case series of low flow veno-venous extracorporeal carbon dioxide removal use in patients with respiratory failure

Moss C.E., Galtrey E., Gillon S., Langrish C., Meadows C., Wyncoll D., Ioannou N., Camporota L., Tricklebank S., Daly K., Evans S., Ong D., Sanderson B., Waldie J., Dando R., Elliott-Hammond C., Lozinski M., Nichols H., Barrett N. Department of Critical Care, Guy’s and St Thomas’ NHS Foundation Trust, London, United Kingdom Poster presentation from the (read more)

University of Maryland Second in USA to use Hemolung RAS

Hemolung RAS used under emergency use rules to facilitate extubation and lung recovery in a patient with COPD due to alpha-1 antitrypsin deficiency. (read more)

Online Course: Introduction to Respiratory Dialysis

22 December 2014 Recent News

You can now view all three Respiratory Dialysis webinars presented by ECCO2R expert Dr. Vito Fanelli. Dr. Fanelli is an assistant professor of Anesthesia and Critical Care Medicine at the University of Turin. Part 1: Physiology of Extracorporeal CO2 Removal Part 2: Applications in Acute Exacerbation of COPD Part 3: ECCO2R in ARDS (read more)

Updates on Respiratory Dialysis – October 2014

10 October 2014 Recent News

The latest news and developments related to extracorporeal CO2 removal and the Hemolung RAS. New Case Report: Use of Respiratory Dialysis to Enable Lung Protective Ventilation in a Patient with Moderate ARDS due to Crush Syndrome from a Mining Accident A 41 year old male copper mine worker who developed moderate acute respiratory distress syndrome (ARDS) (read more)

Updates on Respiratory Dialysis – September 2014

26 August 2014 Recent News

The latest news and developments related to extracorporeal CO2 removal and the Hemolung RAS. Opportunities for ECCO2R Education ESICM Pre-Course: Fundamentals of Extracorporeal CO2 Removal Sunday 28 September 2014 1:30 PM to 4:00 PM Hotel Barceló Atenea Mar, Barcelona Join us for this special pre-ESICM educational event in Barcelona! “Fundamentals of Extracorporeal CO2 Removal (ECCO2R)” will address practical questions about ECCO2R (read more)

ALung Recruiting Nurse User Group

11 August 2014 Recent News

Note: Registration for these sessions is now closed. ALung is recruiting ICU nurses to be part of a User Advisory Group. Participants will work directly with ALung’s engineering and clinical staff, helping test new designs and enhancements of the Hemolung RAS. We have an immediate need for 10 nurses to participate in user testing sessions (read more)

First US Patient Supported with the Hemolung RAS

2 July 2014 Recent News

Suffering from cystic fibrosis and rejecting the transplanted lungs he had gotten just two years ago, Jon Sacker, 33, came to UPMC in Pittsburgh from his hometown in Moore, Oklahoma, as a last resort. But when his carbon dioxide levels spiked, he became too sick to be immediately relisted for transplant. He was also too (read more)

Updates on Extracorporeal CO2 Removal – June 2014

30 June 2014 Recent News

The latest news and developments related to extracorporeal CO2 removal and the Hemolung RAS. Hemolung RAS Recipient of Gold Award at Medical Design Excellence Awards The Hemolung RAS has won the Gold Award in the Critical-Care and Emergency Medicine Category of the 17th Annual Medical Design Excellence Awards (MDEA) competition. The announcement was recently made during (read more)

Initial Australian Experience with the Hemolung RAS presented at EURO-ELSO

Dr. Hergen Buscher of St. Vincent’s Hospital (Sydney, Australia) recently presented the initial Australian Hemolung RAS experience at the EURO-ELSO 2014 conference in Paris. In his report, three COPD patients suffering acute exacerbations and deemed to be at a high risk of being intubated were successfully treated with the Hemolung RAS. View the Poster    (read more)